Quantitative and qualitative analysis of the quality of life of Type 1 diabetes patients using insulin pumps and of those receiving multiple daily insulin injections.

dc.contributor.author

Tzivian, Lilian

dc.contributor.author

Sokolovska, Jelizaveta

dc.contributor.author

Grike, Anna E

dc.contributor.author

Kalcenaua, Agate

dc.contributor.author

Seidmann, Abraham

dc.contributor.author

Benis, Arriel

dc.contributor.author

Mednis, Martins

dc.contributor.author

Danovska, Ieva

dc.contributor.author

Berzins, Ugis

dc.contributor.author

Bogdanovs, Arnolds

dc.contributor.author

Syundyukov, Emil

dc.date.accessioned

2025-08-09T02:34:00Z

dc.date.available

2025-08-09T02:34:00Z

dc.date.issued

2022-08

dc.description.abstract

Introduction

Insulin pump therapy represents an alternative to multiple daily injections and can improve glycemic control and quality of life (QoL) in Type 1 diabetes mellitus (T1DM) patients. We aimed to explore the differences and factors related to the T1DM-specific QoL of such patients in Latvia.

Design and methods

A mixed-method cross-sectional study on 87 adult T1DM patients included 20 pump users and 67 users of injections who participated in the quantitative part of the study; 8 pump users and 13 injection users participated in the qualitative part. Patients were invited to participate using a dedicated digital platform. Their QoL and self-management habits were assessed using specially developed questionnaires adapted to Latvian conditions. Multiple logistic regression models were built to investigate the association between social and self-management factors and patients' QoL. In addition, qualitative analysis of answers was performed.

Results

Insulin pump users were younger, had higher incomes, and reported higher T1DM expenses than users of multiple daily injections. There were no differences in self-management between the groups; Total QoL differed at the 0.1 significance level. In fully adjusted multiple logistic regression models, the most important factor that increased Total QoL was lower T1DM-related expenses (odds ratio, OR 7.02 [95% confidence interval 1.29; 38.0]). Men and those with more years of living with T1DM had better QoL (OR 9.62 [2.20; 42.1] and OR 1.16 [1.05; 1.29], respectively), but the method of administration was not significantly associated with QoL (OR 7.38 [0.87; 62.9]). Qualitative data supported the results of quantitative analysis.

Conclusions

QoL was the main reason to use an insulin pump, while the expense was the main reason to avoid the use of it or to stop using it. Reimbursement policies thus should be considered to enable patients to choose the more convenient method for themselves.
dc.identifier

10.1186/s12955-022-02029-2

dc.identifier.issn

1477-7525

dc.identifier.issn

1477-7525

dc.identifier.uri

https://hdl.handle.net/10161/33091

dc.language

eng

dc.publisher

Springer Science and Business Media LLC

dc.relation.ispartof

Health and quality of life outcomes

dc.relation.isversionof

10.1186/s12955-022-02029-2

dc.rights.uri

https://creativecommons.org/licenses/by-nc/4.0

dc.subject

Humans

dc.subject

Diabetes Mellitus, Type 1

dc.subject

Insulin

dc.subject

Hypoglycemic Agents

dc.subject

Insulin Infusion Systems

dc.subject

Cross-Sectional Studies

dc.subject

Quality of Life

dc.subject

Adult

dc.subject

Female

dc.subject

Male

dc.subject

Glycated Hemoglobin

dc.title

Quantitative and qualitative analysis of the quality of life of Type 1 diabetes patients using insulin pumps and of those receiving multiple daily insulin injections.

dc.type

Journal article

duke.contributor.orcid

Benis, Arriel|0000-0002-9125-8300

pubs.begin-page

120

pubs.issue

1

pubs.organisational-group

Duke

pubs.organisational-group

Pratt School of Engineering

pubs.organisational-group

Biomedical Engineering

pubs.publication-status

Published

pubs.volume

20

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Quantitative and qualitative analysis of the quality of life of Type 1 diabetes patients using insulin pumps and of those re.pdf
Size:
1.35 MB
Format:
Adobe Portable Document Format